Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy with Docetaxel and 5-FU vs Cisplatin in Metastatic Pancreatic Cancer
NCT00112697Phase 2Completed
- Sponsor
- Unicancer
- Start
- Oct 2003
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in pancreatic cancer (PC), sponsored by Unicancer. Started Oct 2003; status: completed.
02
Drugs
docetaxel
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00112697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112697.